is semaglutide bad for your kidneys Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine is semaglutide bad for your

Nearly 9% of the patients taking semaglutide had NAION, compared to only 1.8% of patients who were not taking semaglutide

TDN, in particular, may represent a complementary anti-obesity or anti-diabetes agent with the benefits of weight and glucose control, but without the gastrointestinal side effects that often limit GLP-1 therapies

The Journal of Nutritio n vol

Adding cagrilintide to retatrutide may temporarily exacerbate fatigue during the titration phase, particularly if caloric intake drops significantly

For patients considering GLP-1 after thyroid surgery, understanding the intersection of thyroid hormone balance and weight management is essential

Zepbound (Tirzepatide) Zepbound represents a powerful choice for enhanced weight loss outcomes, targeting both GLP-1 and GIP hormones